APTO Insider Trading Activity and SEC Form 4 Filings
APTO insider trading summary
No open-market insider purchases or sales of Aptose Biosciences Inc. (APTO) have been reported on SEC Form 4 in the past 12 months.
Latest APTO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 25, 2024 | William G. Rice | Chair, President & CEO | Buy | $20K (100,000 @ $0.20) |
| Sep 22, 2023 | Bernd R. Seizinger | Insider | Buy | $53K (17,000 @ $3.14) |
| Sep 19, 2022 | Fletcher Payne | SR VP & Chief Fin. Officer | Buy | $7K (10,000 @ $0.68) |
| Sep 19, 2022 | William G. Rice | Chair, President & CEO | Buy | $7K (10,000 @ $0.68) |
| Jun 6, 2022 | William G. Rice | Chair, President & CEO | Buy | $10K (10,000 @ $0.97) |
| Dec 20, 2021 | Denis R Burger | Director | Buy | $14K (10,000 @ $1.45) |
| Dec 16, 2021 | Erich Platzer | Director | Buy | $28K (20,000 @ $1.40) |
| Dec 16, 2021 | Erich Platzer | Director | Buy | $69K (50,000 @ $1.37) |
| Dec 16, 2021 | William G. Rice | Chair, President & CEO | Buy | $20K (13,183 @ $1.52) |
| Dec 16, 2021 | Erich Platzer | Director | Buy | $41K (30,000 @ $1.38) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.